{"product_id":"pp-10","title":"CJC-1295 + Ipamorelin","description":"\u003cp\u003eThis research blend combines CJC-1295, a synthetic GHRH analog, with Ipamorelin, a pentapeptide ghrelin-receptor (GHS) agonist. Laboratory research has studied the pair for complementary activity on growth-hormone-axis signaling models. Supplied as lyophilized material for qualified in-vitro research.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eCompound specifications:\u003c\/strong\u003e Lyophilized powder in sealed vials. Purity verified at ≥99% by independent third-party HPLC analysis. Store in a cool, dry environment; refrigerate after reconstitution per standard laboratory protocol.\u003c\/p\u003e\u003cdiv class=\"pp-product-notes\"\u003e\n\n\n\u003cdiv class=\"pp-product-notes__item\"\u003e\n\u003cp class=\"pp-product-notes__label\"\u003eResearch use notice\u003c\/p\u003e\n\u003cp\u003eReserved for qualified in-vitro laboratory research only. Not for human consumption, veterinary use, clinical, diagnostic, or therapeutic use. Purchasers must be 21 years of age or older and accept the Research Use Only Agreement before ordering.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\n\u003ch2\u003eWhat is CJC-1295 + Ipamorelin?\u003c\/h2\u003e\n\u003cp\u003eThis research blend combines two of the most studied growth-hormone-axis secretagogues: CJC-1295, a synthetic analog of growth hormone–releasing hormone (GHRH 1-29) with four strategic amino-acid substitutions that resist enzymatic degradation, and Ipamorelin, a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) recognized in the literature as the first highly selective growth-hormone secretagogue.\u003c\/p\u003e\n\u003cp\u003eThe pairing is a standard reference combination in GH-axis research because the two compounds act on distinct receptor systems — GHRH receptor and ghrelin\/GHS receptor respectively — allowing researchers to study complementary secretagogue signaling in a single preparation. Supplied as high-purity lyophilized material strictly for qualified research use.\u003c\/p\u003e\n\u003ch2\u003eMechanism of Action — Research Overview\u003c\/h2\u003e\n\u003cp\u003eCJC-1295 (Modified GRF 1-29) engages the GHRH receptor on pituitary somatotroph models, driving cAMP-mediated growth-hormone-release signaling within endogenous feedback architecture. Ipamorelin engages the growth-hormone secretagogue receptor (GHS-R1a, the ghrelin receptor) and is noted in the literature for its selectivity — stimulating GH-release signaling without the broader hormonal spillover observed with earlier secretagogues in study models.\u003c\/p\u003e\n\u003cp\u003eResearch models of the combination examine synergistic amplitude effects on pulsatile GH release: the GHRH-pathway component supporting somatotroph synthesis and priming, the GHS-R1a component amplifying pulse release.\u003c\/p\u003e\n\u003ch2\u003eResearch Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eGHRH\/GH\/IGF-1 axis signaling research\u003c\/li\u003e\n\u003cli\u003eGhrelin-receptor (GHS-R1a) pharmacology studies\u003c\/li\u003e\n\u003cli\u003eDual-secretagogue synergy models\u003c\/li\u003e\n\u003cli\u003ePulsatile hormone-release research\u003c\/li\u003e\n\u003cli\u003eComparative secretagogue-selectivity studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eCJC-1295 + Ipamorelin Specifications\u003c\/h2\u003e\n\u003ctable\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLyophilized blend in sealed 3 mL glass vial (10mg CJC-1295 + 5mg Ipamorelin)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCJC-1295\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCAS 863288-34-0; formula C165H269N47O46; ≈ 3647.2 g\/mol; PubChem CID 91971820; synonyms: Modified GRF(1-29)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eIpamorelin\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCAS 170851-70-4; formula C38H49N9O5; ≈ 711.9 g\/mol; PubChem CID 9831659; synonyms: Aib-His-D-2-Nal-D-Phe-Lys-NH2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStore lyophilized at −20°C, sealed, protected from light and moisture. Refrigerate after reconstitution per standard laboratory protocol.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e\n\u003ch2\u003eLaboratory Handling \u0026amp; Storage\u003c\/h2\u003e\n\u003cp\u003eStandard lyophilized-peptide handling for both components: sterile technique, PPE, moisture protection, and lot documentation for each batch.\u003c\/p\u003e\n\u003ch2\u003eCertificate of Analysis \u0026amp; Quality Assurance\u003c\/h2\u003e\n\u003cp\u003eEvery batch of CJC-1295 + Ipamorelin is verified by independent analytical testing (identity and purity). The certificate of analysis for the current batch is linked on this page. Documentation of test date and method accompanies each batch.\u003c\/p\u003e\n\u003ch2\u003eReferences\u003c\/h2\u003e\n\u003col\u003e\n\u003cli\u003eProlonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. \u003cem\u003eJ Clin Endocrinol Metab\u003c\/em\u003e. 2006. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16352683\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID: 16352683\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eIpamorelin, the first selective growth hormone secretagogue. \u003cem\u003eEur J Endocrinol\u003c\/em\u003e. 1998. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9849822\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID: 9849822\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cem\u003eNote: CJC-1295 + Ipamorelin is supplied strictly for laboratory research use only. It is not approved for human or veterinary use, and nothing on this page is medical advice or a health claim. All described findings reflect preclinical or published research contexts.\u003c\/em\u003e\u003c\/p\u003e\n\u003ch2\u003eShipping, Handling \u0026amp; Guarantee\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFast U.S. shipping:\u003c\/strong\u003e Orders placed before 2:00 PM CT ship the same business day from Minneapolis, MN. Free shipping on orders over $100.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLab safety profile:\u003c\/strong\u003e Supplied for laboratory research use only. Handle using appropriate personal protective equipment in a suitable laboratory setting. Not for human or veterinary use.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrder guarantee:\u003c\/strong\u003e If your order arrives damaged, incorrect, or incomplete, contact us within 48 hours of delivery with photos and we will make it right. See our \u003ca href=\"\/policies\/refund-policy\"\u003eReturn \u0026amp; Refund Policy\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Prestige Peptides","offers":[{"title":"10mg + 5mg \/ 1 Vial","offer_id":50520205983987,"sku":"pp-cj2-10-1v","price":55.0,"currency_code":"USD","in_stock":true},{"title":"10mg + 5mg \/ 3 Vials","offer_id":50240939196659,"sku":"pp-cj2-10-3v","price":140.25,"currency_code":"USD","in_stock":true},{"title":"10mg + 5mg \/ 5 Vials","offer_id":50240939229427,"sku":"pp-cj2-10-5v","price":206.25,"currency_code":"USD","in_stock":true},{"title":"10mg + 5mg \/ 10 Vials","offer_id":50279141998835,"sku":null,"price":357.5,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0839\/9857\/2787\/files\/cjc-1295-ipamorelin-approved-wider-panel_db6bbcf1-7ce1-4a33-8cb6-4cc56e53d4e4.png?v=1788221444","url":"https:\/\/prestigepeptides.us\/products\/pp-10","provider":"Prestige Peptides","version":"1.0","type":"link"}